FindTrial
Sign In

Study to evaluate the efficacy of indigenous drugs in the management of Anemia in pregnancy

Clinical study to evaluate the efficacy of indigenous drugs formulation in the management of Garbhini Pandu with special reference to anemia in pregnancy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109565
Enrollment
30
Registered
2026-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

Dr Priyanka Yadav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pregnant women aged 18 to 35 years, from 12 weeks of pregnancy onwards till term. 2. Patient having Hb % between 7.0gm/dl to 10.9gm/dl. 3. Patient with clinical signs and symptoms of Pandu described in Ayurvedic classical and modern literature

Exclusion criteria

Exclusion criteria: Hb less than 7g/dl (severe Anemia) or requirement for immediate parenteral iron/ blood transfusion. Known haemoglobinopathies (like thalassemia trait/ major, sickle cell disease, pernicious Anemia). Patient with high-risk pregnancy. Known allergy to any study ingredients.

Design outcomes

Primary

MeasureTime frame
Improvement in Hb% levels (more than 3 g/dl increase) from baseline to 90 days.Timepoint: Improvement in Hb% levels (more than 3 g/dl increase) from baseline to 90 days.—

Secondary

MeasureTime frame
Reduction in Pandu symptoms (Pallor/Panduta, Daurbalya, Hridrava, Aruchi) graded 0-4; hematological parameters (RBC, PCV, MCV, MCH, MCHC).Timepoint: Days 15, 30, 45, 60, 75, 90—

Countries

India

Contacts

Public ContactProf Dr Mayank Kesharwanee

Chandra Shekhar Singh Ayurvedic Sansthan, koilaha, kaushambi

priyankacy17@gmail.com08080324434

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026